These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21036837)

  • 1. Outcomes of multidrug-resistant tuberculosis among binational cases in El Paso, Texas.
    Ferrer G; Acuna-Villaorduna C; Escobedo M; Vlasich E; Rivera M
    Am J Trop Med Hyg; 2010 Nov; 83(5):1056-8. PubMed ID: 21036837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and risk factors of drug-resistant tuberculosis along the Mexico-Texas border.
    Taylor JP; Suarez L
    Am J Public Health; 2000 Feb; 90(2):271-3. PubMed ID: 10667190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis along the United States-Mexico border, 1993-2001.
    Schneider E; Laserson KF; Wells CD; Moore M
    Rev Panam Salud Publica; 2004 Jul; 16(1):23-34. PubMed ID: 15333263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of Primary Multidrug-Resistant Tuberculosis, Vladimir Region, Russia.
    Ershova JV; Volchenkov GV; Kaminski DA; Somova TR; Kuznetsova TA; Kaunetis NV; Cegielski JP; Kurbatova EV
    Emerg Infect Dis; 2015 Nov; 21(11):2048-51. PubMed ID: 26488585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Representative drug susceptibility patterns for guiding design of re-treatment regimens for multidrug-resistant tuberculosis in Iran.
    Tabarsi P; Nooraki A; Mirsaeidi M; Amiri M; Baghaei P; Farnia P; Kazempour M; Heidarnazhad H; Alipanah N; Mansouri D; Masjedi MR
    Respirology; 2008 Jan; 13(1):108-11. PubMed ID: 18197919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug-resistant tuberculosis in Alberta and British Columbia, 1989 to 1998.
    Hersi A; Elwood K; Cowie R; Kunimoto D; Long R
    Can Respir J; 1999; 6(2):155-60. PubMed ID: 10322098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of country of origin on drug-resistant tuberculosis among foreign-born persons in British Columbia.
    Moniruzzaman A; Elwood RK; Schulzer M; FitzGerald JM
    Int J Tuberc Lung Dis; 2006 Aug; 10(8):844-50. PubMed ID: 16898367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extensively drug-resistant tuberculosis in california, 1993-2006.
    Banerjee R; Allen J; Westenhouse J; Oh P; Elms W; Desmond E; Nitta A; Royce S; Flood J
    Clin Infect Dis; 2008 Aug; 47(4):450-7. PubMed ID: 18616396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited Scope of Shorter Drug Regimen for MDR TB Caused by High Resistance to Fluoroquinolone.
    Singh PK; Jain A
    Emerg Infect Dis; 2019 Sep; 25(9):1760-1762. PubMed ID: 31441763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of clinical profile of cases of MDR-TB and evaluation of challenges faced in initiation of second line Anti tuberculosis treatment for MDR-TB cases admitted in drug resistance tuberculosis center.
    Mukati S; Julka A; Varudkar HG; Singapurwala M; Agrawat JC; Bhandari D; Jain A
    Indian J Tuberc; 2019 Jul; 66(3):358-363. PubMed ID: 31439180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and factors associated with multidrug/rifampicin resistant tuberculosis among suspected drug resistant tuberculosis patients in Botswana.
    Tembo BP; Malangu NG
    BMC Infect Dis; 2019 Sep; 19(1):779. PubMed ID: 31492099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
    Becerra MC; Freeman J; Bayona J; Shin SS; Kim JY; Furin JJ; Werner B; Sloutsky A; Timperi R; Wilson ME; Pagano M; Farmer PE
    Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug-resistant tuberculosis in Rawalpindi, Pakistan.
    Khurram M; Khaar HT; Fahim M
    J Infect Dev Ctries; 2012 Jan; 6(1):29-32. PubMed ID: 22240425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997].
    Augustynowicz-Kopeć E; Zwolska Z; Jaworski A; Kostrzewa E; Klatt M; Swiderska A; Drozd I
    Pneumonol Alergol Pol; 2002; 70(3-4):193-202. PubMed ID: 12271966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of multidrug-resistant tuberculosis in a high-prevalence region through a binational consortium.
    Laniado-Laborín R; Estrada-Guzman J; Perez H; Batiz-Armenta F; Alcantar-Schramm JM
    Int J Tuberc Lung Dis; 2012 May; 16(5):610-1. PubMed ID: 22410353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-resistance pattern of Mycobacterium tuberculosis strains from patients with pulmonary and extrapulmonary tuberculosis during 2006 to 2013 in a Korean tertiary medical center.
    Lee HY; Lee J; Lee YS; Kim MY; Lee HK; Lee YM; Shin JH; Ko Y
    Korean J Intern Med; 2015 May; 30(3):325-34. PubMed ID: 25995663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes is Associated with Severe Adverse Events in Multidrug-Resistant Tuberculosis.
    Muñoz-Torrico M; Caminero-Luna J; Migliori GB; D'Ambrosio L; Carrillo-Alduenda JL; Villareal-Velarde H; Torres-Cruz A; Flores-Vergara H; Martínez-Mendoza D; García-Sancho C; Centis R; Salazar-Lezama MÁ; Pérez-Padilla R
    Arch Bronconeumol; 2017 May; 53(5):245-250. PubMed ID: 28089216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
    Gupta R; Espinal MA; Raviglione MC
    Int J Tuberc Lung Dis; 2000 Nov; 4(11):1089-91. PubMed ID: 11092726
    [No Abstract]   [Full Text] [Related]  

  • 19. Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with Standard Short-Course Chemotherapy for tuberculosis.
    Gao J; Ma Y; Du J; Zhu G; Tan S; Fu Y; Ma L; Zhang L; Liu F; Hu D; Zhang Y; Li X; Li L; Li Q
    BMC Pulm Med; 2016 Feb; 16():26. PubMed ID: 26846562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time to initiation of multidrug-resistant tuberculosis treatment and its relation with outcome in a high incidence district in Lima, Peru.
    Otero L; De Orbegoso A; Navarro AF; Ríos J; Párraga T; Gotuzzo E; Seas C; Van der Stuyft P
    Trop Med Int Health; 2015 Mar; 20(3):322-5. PubMed ID: 25429916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.